Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg

NCT00648063 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Letrozole Tablets 2.5 mg
DRUG: Femara® Tablets 2.5 mg

Sponsor

Mylan Pharmaceuticals Inc